Análisis de la cuota de mercado y oportunidades de la terapéutica para trastornos neurológicos (2025-2031)
Neurologic Disorders Therapeutics Market Report Analysis
Neurologic Disorders Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Biogen Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Novartis AG
- Pfizer Inc.
- Sage Therapeutics, Inc
- Boehringer Ingelheim International GmbH
- Bayer AG
- GlaxoSmithKline plc
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Indicación
- Enfermedades de Parkinson
- Enfermedades de Alzheimer
- Trastornos psicóticos
- Trastornos epilépticos
- Trastornos de autismo
- Enfermedades de tumores cerebrales
By Clase de fármaco
- inhibidores de la ECA
- antagonista de NMDA
- antagonistas D2
- otros
By Aplicación [Sistema Nervioso Central
- SNC
- Sistema Nervioso Periférico
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
Get Free Sample For